Prometheus | Protein Stability + Aggregation + Particle Sizing
-
1:41WatchPrometheus Panta: The new gold standard for biologics characterization
Choosing the right stability characterization tool for your biologics research is a big commitment. You’re going to be screening and optimizing lots of candidates, and you’ll need data on thermal stab
-
ReadHow early discovery and development teams use Dynamic Light Scattering to de-risk downstream biologics development
As a discovery or early development scientist, you’re tasked with identifying the most promising biologics candidates. Your hard work during early development enables straightforward and efficient...
-
4:51WatchFour integrated technologies for Biologics developability assessment
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stability information to develop successful biologics
-
Read
The biologics researcher's guide to DLS
-
Read
Top 8 biologics conferences of 2023 at a glance
Use this downloadable list of 2023 biologics conferences to select which one to attend. Learn when and where they’ll happen, who’ll be there, and the main focus.
-
Ready to tackle your challenging stability characterizations?
Discover tools -
34:16WatchDLS easily explained: What it tells you about your protein
Join this webinar to learn about the physical phenomenon that drives Dynamic Light Scattering (DLS), and see a few examples of how DLS gives you deeper insights.
-
2:34WatchHow 2bind identifies the best buffer for a vaccine antigen target with Prometheus Panta
Discover how 2bind applied multi-parameter characterization from a single experiment to find the optimal buffer for a vaccine antigen target.
-
Read
Biologics developability: learn how Merck uses Prometheus Panta to create developability profiles for their mAbs
-
Read
Select the best biologics candidates with high-quality, multi-parameter stability characterization
-
1:31WatchHow Janssen optimizes the stability of a therapeutic mAb
Discover how Janssen improved the stability of a promising prostate cancer targeting mAb. You’ll learn why it is important to optimize stability measurements of a therapeutic mAb.
-
Read
Use stability profiling to build more effective gene therapy vectors with Prometheus Panta
-
ReadNanoTemper Technologies arms gene therapy scientists with Static Light Scattering to sharpen their tool kit for development of AAVs
SOUTH SAN FRANCISCO, Calif Feb 16 2022 — NanoTemper Technologies today announced the addition of Static Light Scattering (SLS) to their wildly successful Prometheus Panta, turning their instrument...
-
14:07WatchSerotyping: why, when, and how to assess your AAV therapeutic to get it approved
When you develop an AAV therapeutic, you need to assess many key parameters, or Critical Quality Attributes (CQAs), in order to track progress and, ultimately, get your therapeutic approved. As part
-
ReadWays light scattering technologies help you if you’re in gene therapy
-
Read8 biologics conferences you won’t want to miss in 2023
When you’re part of an industry that moves quickly, it’s important to keep up. You hear about biotherapeutics approvals, and big pharma news, but nothing matches the biologics conference experience.
-
ReadLearn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors
-
Read5 benefits of optimizing your formulation buffer to get your AAV therapeutic approved
As a gene therapy scientist, you face an abundance of challenges when working to build an effective AAV therapeutic. Many steps of the development workflow have yet to be standardized and the...
-
Read
Four technologies to profile your AAVs
-
Read
How Merck KGaA uses light scattering measurements for better developability assessment of biologic therapeutics
-
ReadHow stability studies get your mAb candidate FDA-approved
-
Loading more...
